STOCK TITAN

BioLife Solutions: T. Rowe Price lists 2.2% position

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

BioLife Solutions, Inc. (BLFS) is the issuer in an amended Schedule 13G that lists 1,094,026 common shares as beneficially owned by T. Rowe Price Investment Management, Inc., equal to 2.2% of the class. The table reports sole voting and dispositive power over all 1,094,026 shares and no shared power. T. Rowe Price Investment Management expressly denies being the beneficial owner of the securities.

Shares listed as beneficially owned 1,094,026 shares T. Rowe Price Investment Management, Inc.; the accompanying statement expressly denies beneficial ownership.
Class percentage 2.2% Percentage reported for the listed shares.
Sole voting and dispositive power 1,094,026 shares Reported for T. Rowe Price Investment Management, Inc.
Shared voting and dispositive power 0 shares Reported for T. Rowe Price Investment Management, Inc.
beneficial ownership regulatory
"expressly denies being the beneficial owner"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
sole dispositive power regulatory
"Sole power to dispose or to direct the disposition"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BLFS shares did T. Rowe Price Investment Management report?

T. Rowe Price Investment Management, Inc.'s amendment lists 1,094,026 BioLife common shares as beneficially owned, equal to 2.2% of the class. It reports sole voting and dispositive power over that amount and zero shared voting and dispositive power. The reporting person also expressly denies beneficial ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





09062W204

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Investment Management, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:11/16/2026

Keep reading